Cardiac Arrhythmia Telemetry Comparing Conventional Holter Monitor and HeartWatch Device

What this Trial Is About

Heart rhythm disorders such as atrial fibrillation, atrial flutter, supraventricular tachycardia, bradycardia, and ventricular arrhythmias affect many people and can significantly impact their lives and families. Detecting these conditions is challenging with current devices, which are either worn for short periods or require invasive implantation. This trial compares a new longer-term monitoring device called HeartWatch, worn on the upper arm and paired with a smartphone app, against the conventional Holter monitor to evaluate their accuracy and reliability in detecting heart electrical signals. Participants referred for a Holter monitor test will wear both the Holter monitor and the HeartWatch simultaneously for 24 to 48 hours. HeartWatch is an armband device worn on the left upper arm that collects heart signals and uploads them securely for analysis via a paired smartphone app. The study will compare the quality of signal detection and heart electrical measurements between the two devices and assess adverse events and patient preferences. During the study, participants will be monitored while wearing both devices for up to two days. Researchers will evaluate heart signal characteristics such as QRS complex detection and ECG intervals during this time. Participants will provide written consent and must be able to wear the HeartWatch on their left arm. Safety and device performance will be closely monitored, and the total participation time corresponds to the device wear period of 24 to 48 hours.

Cardiac Arrhythmia Telemetry; Conventional vs HeartWatch